Citigroup analyst Yigal Nochomovitz maintains Macrogenics (NASDAQ:MGNX) with a Buy and raises the price target from $13 to $16.
Tesla Q2 EPS $2.27 Beats $1.91 Estimate, Sales $16.93B Miss $17.39B Estimate
Tesla (NASDAQ:TSLA) reported quarterly earnings of $2.27 per share which beat the analyst consensus estimate of $1.91 by 18.85 percent. This is a 56.55 percent increase over earnings of $1.45 per share from the same
